wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38371740-047A4536-279D-48B2-A531-7ECACBF05C40
Q38371740-047A4536-279D-48B2-A531-7ECACBF05C40
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38371740-047A4536-279D-48B2-A531-7ECACBF05C40
Alemtuzumab CARE-MS I 5-year follow-up: Durable efficacy in the absence of continuous MS therapy.
P2860
Q38371740-047A4536-279D-48B2-A531-7ECACBF05C40
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38371740-047A4536-279D-48B2-A531-7ECACBF05C40
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ed7c017329a56296bb5d15e386c3c0f60528edde
P2860
New developments in the diagnosis and treatment of thyroid cancer.